The toxicity and pharmacologic properties of rifamycin SV
Gol'dberg, L.E.; Filippos'iants, S.T.; Muraveiskaia, V.S.; Vertogradova, T.P.; Belova, I.P.
Antibiotiki 19(4): 344-350
1974
ISSN/ISBN: 0003-5637 PMID: 4463873 Document Number: 75413
Document emailed within 1 workday
Related Documents
1974: Pharmacologic action and toxicity of anthorhododendrin Zhonghua yi xue za zhi 5: 279-283Schwartz, S.G.; Grzybowski, A.; Wasinska-Borowiec, W.; Flynn, H.W.; Mieler, W.F. 2015: Update on Pharmacologic Retinal Vascular Toxicity Current Pharmaceutical Design 21(32): 4694-4697
Rasmussen, L.F.; Wennberg, R.P. 1972: Pharmacologic modification of bilirubin toxicity in tissue culture cells Research Communications in Chemical Pathology and Pharmacology 3(3): 567-578
Labrid, C. 1994: Pharmacologic properties of Daflon 500 mg Angiology 45(6 Pt 2): 524-530
Schipper, J. 1992: Fluvoxamine--pharmacologic properties Ceskoslovenska Psychiatrie 88(5): 225
Lecomte, J.; Van Cauwenberge, H. 1971: Pharmacologic properties of bioflavonoids Revue Medicale de Liege 26(20): 673-681
Fehri, B.; Aiache, J.M.; Boukef, K.; Memmi, A.; Hizaoui, B. 1991: Valeriana officinalis and Crataegus oxyacantha: toxicity from repeated administration and pharmacologic investigations Journal de Pharmacie de Belgique 46(3): 165-176
Burlakov, G.V. 1989: Pharmacologic properties of cholinoreceptor antibodies Biulleten' Eksperimental'noi Biologii i Meditsiny 108(9): 320-322
Cebo, B.; Krupińska, J.; Mazur, J. 1979: Pharmacologic properties of some derivatives of N-(2-carboxyphenyl)-4-phenoxyacetamide Archivum Immunologiae et Therapiae Experimentalis 27(3): 415-424
Legheand, J.; Boiron, J.; Cier, A. 1977: Pharmacologic properties of ortho-ethoxy-benzamide Annales Pharmaceutiques Francaises 35(9-10): 387-398
Montoya-Cabrera, M.A.; López-Martín, G.; Hernández-Zamora, A. 1984: Treatment of aminophylline poisoning according to its pharmacologic properties Gaceta Medica de Mexico 120(9-10): 347-350
Thunus, L.; Lapiere, C.L. 1975: Synthesis and pharmacologic properties of some hydroxyethylpiperazinylpyridines (substitutions at 2-3 and 3-4) Annales Pharmaceutiques Francaises 33(12): 663-669
Dorr, R.T.; Alberts, D.S.; Einspahr, J.; Mason-Liddil, N.; Soble, M. 1987: Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes Cancer Treatment Reports 71(3): 267-272
Hall, S.W.; Valdivieso, M.; Benjamin, R.S. 1977: Intermittent high single-dose ftorafur: phase i clinical trial with a pharmacologic-toxicity correlation Cancer Treatment Reports 61(8): 1495-1498
Schulz, E.; Sprung, W.D.; Kröning, G.; Vietinghoff, G. 1978: The synthesis and pharmacologic properties of N-alkylester homologs of d,1-2-phenylglycine Die Pharmazie 33(11): 749-753
Wilimowski, M.; Kedzierska, L.; Barczyńska, J.; Prandota, J. 1970: Pharmacologic properties of derivatives of 3-phenyl-3-hydroxyglutaric acid Archivum Immunologiae et Therapiae Experimentalis 18(2): 270-279
Casadio, S.; Cousse, H.; Mouzin, G.; Stenger, A.; Charveron, M.; Vilain, P.; Lauressergues, H. 1978: New beta-phenethylamine derivatives: Synthesis and pharmacologic properties Bollettino Chimico Farmaceutico 117(2): 83-89
Kleinrok, Z.; Kozicka, M.; Tobiasz-Otrebska, K.; Sermak, W. 1985: Pharmacologic properties of new 5-benzylidene derivatives of 3-m-nitrophenyl-2-thiohydantoin Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 40: 169-176
Guryn, R.; Szadowska, A.; Kiełek, M.B. 1988: Synthesis and pharmacologic properties of s-triazolo-1,4-diazepine derivatives Acta Poloniae Pharmaceutica 45(6): 512-516
Thunus, L. 1977: Synthesis and pharmacologic properties of various isopropyl and 2,5-substituted hydroxyethylpiperazinylpyridines Annales Pharmaceutiques Francaises 35(5-6): 197-204